Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
International Journal of Cell Biology|November 29, 2013
U1 snRNP-Dependent Suppression of Polyadenylation: Physiological Role and Therapeutic Opportunities in CancerLee Spraggon, Luca Cartegni
Drug Discovery Today. Therapeutic Strategies|January 16, 2015
Antisense Modulation of RNA Processing as a Therapeutic Approach in Cancer TherapyLee Spraggon, Luca Cartegni
Molecular and Cellular Biology|March 18, 2003
Mice lacking the 68-amino-acid, mammal-specific N-terminal extension of WT1 develop normally and are fertileColin G Miles, Joan Slight, Lee Spraggon, et al.
The Journal of Cell Biology|August 15, 2012
Mammalian GW220/TNGW1 is essential for the formation of GW/P bodies containing miRISCVirginia Castilla-Llorente, Lee Spraggon, Miwako Okamura, et al.
Human Molecular Genetics|December 3, 2003
Development of an siRNA-based method for repressing specific genes in renal organ culture and its use to show that the Wt1 tumour suppressor is required for nephron differentiationJamie A Davies, Michael Ladomery, Peter Hohenstein, et al.
Cancer Research|November 20, 2002
Genetic interactions between the Wilms' tumor 1 gene and the p53 geneAswin L Menke, Alan R Clarke, Andrea Leitch, et al.
Human Molecular Genetics|August 14, 2003
Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosisCharles E Patek, Stewart Fleming, Colin G Miles, et al.
Plos One|January 7, 2014
Stromal protein Ecm1 regulates ureteric bud patterning and branchingSuneeta S Paroly, Fengwei Wang, Lee Spraggon, et al.
The Journal of Pathology|August 5, 2003
The wt1-heterozygous mouse; a model to study the development of glomerular sclerosisAswin L Menke, Annemieke IJpenberg, Stewart Fleming, et al.
The Journal of Pathology|February 12, 2017
Generation of conditional oncogenic chromosomal translocations using CRISPR-Cas9 genomic editing and homology-directed repairLee Spraggon, Luciano G Martelotto, Julija Hmeljak, et al.
Pageof 3